Shingles Vaccines
Shingles Vaccines
Shingles vaccines provide protection from herpes zoster. The disease is caused by the varicella zoster virus which, at the first contact, causes the chicken pox.
| Name | Description | Marketing Authorisation Holder | Kind of Vaccine | License Number | License Date | Further Information |
|---|---|---|---|---|---|---|
|
Shingrix |
Herpes-Zoster-Impfstoff (rekombinant, adjuvantiert) Verwendung ab einem Lebensalter von 50 Jahren / Use from 50 years of age onwards |
GlaxoSmithKline Biologicals S.A., Belgien |
Mono | EU/1/18/1272 | 21.03.2018 | |
|
Zostavax |
Gürtelrose (Herpes zoster)- Lebendimpfstoff Verwendung ab einem Lebensalter von 50 Jahren / Use from 50 years of age onwards |
MSD VACCINS, Lyon, Frankreich |
Mono | EU/1/06/341/001-013 | 19.05.2006 |
Hints
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 477 in BAnz AT 16.02.2021 B7.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 01.03.2021
More Information
More Information
What are the age requirements for vaccines?
Altersangaben für Impfstoffe
Source: PEI
Updated: 01.03.2021
